Sun C, Shan C Y, Gao X D, Tan R X
Institute of Functional Biomolecules, State Key Lab Pharmaceutical Biotechnology, Nanjing University, Nanjing 210093, PR China.
J Biotechnol. 2005 Jan 26;115(2):137-44. doi: 10.1016/j.jbiotec.2004.08.011.
A number of studies indicate that free radicals are involved in the neurodegeneration in Parkinson's and Alzheimer's diseases. EPS2, an exopolysaccharide with a mean molecular weight of 1.3 x 10(5) Da, was isolated by ion-exchange and sizing chromatography from the culture of Keissleriella sp. YS4108, a marine filamentous fungus. Compositionally, it is composed of galactose, glucose, rhamnose, mannose and glucuronic acid in an approximate proportion of 50:8:1:1:0.4. The protective effects of EPS2 on peroxide hydrogen (H2O2)-induced cell lesion, level of lipid peroxidation, antioxidant enzyme activities were investigated in the rat pheochromocytoma line PC12 cells. Following a 1-h exposure of the cells to H2O2, a significant reduction in cell survival and activities of glutathione peroxidase (GSH-Px) and catalase (CAT), as well as increased levels in malondialdehyde (MDA) production and lactate dehydrogenase (LDH) release were observed. However, preincubation of the cells with EPS2 prior to H2O2 exposure elevated the cell survival and GSH-Px and CAT activities, and decreased the level of MDA and LDH activity in a dose-dependent manner. In conclusion, EPS2 possesses pronounced protective effects against H2O2-induced cell toxicity. The finding is of a higher value in searching for new therapeutic agent for treating oxidative damage-derived neurodegenerative disorders.
多项研究表明,自由基参与了帕金森病和阿尔茨海默病的神经退行性变。EPS2是一种平均分子量为1.3×10⁵ Da的胞外多糖,通过离子交换和尺寸排阻色谱从海洋丝状真菌Keissleriella sp. YS4108的培养物中分离得到。其组成成分包括半乳糖、葡萄糖、鼠李糖、甘露糖和葡萄糖醛酸,比例约为50:8:1:1:0.4。在大鼠嗜铬细胞瘤细胞系PC12细胞中研究了EPS2对过氧化氢(H₂O₂)诱导的细胞损伤、脂质过氧化水平和抗氧化酶活性的保护作用。细胞暴露于H₂O₂ 1小时后,观察到细胞存活率、谷胱甘肽过氧化物酶(GSH-Px)和过氧化氢酶(CAT)活性显著降低,丙二醛(MDA)生成量和乳酸脱氢酶(LDH)释放量增加。然而,在H₂O₂暴露前用EPS2预孵育细胞可提高细胞存活率以及GSH-Px和CAT活性,并以剂量依赖方式降低MDA水平和LDH活性。总之,EPS2对H₂O₂诱导的细胞毒性具有显著的保护作用。这一发现对于寻找治疗氧化损伤所致神经退行性疾病的新治疗药物具有较高价值。